These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 37105655)
21. Controlled substance diversion in health systems: A failure modes and effects analysis for prevention. Nolan K; Zullo AR; Bosco E; Marchese C; Berard-Collins C Am J Health Syst Pharm; 2019 Jul; 76(15):1158-1164. PubMed ID: 31408513 [TBL] [Abstract][Full Text] [Related]
22. Do Palliative Care Clinics Screen for Substance Abuse and Diversion? Results of a National Survey. Tan PD; Barclay JS; Blackhall LJ J Palliat Med; 2015 Sep; 18(9):752-7. PubMed ID: 26302425 [TBL] [Abstract][Full Text] [Related]
23. Training experiences regarding pain management, addiction, and drug diversion of dentists enrolled in the National Dental Practice-Based Research Network. McCauley JL; Reyes S; Meyerowitz C; Gordan VV; Rindal DB; Gilbert GH; Leite RS; Fillingim RB; Brady KT; Subst Abus; 2019; 40(3):344-349. PubMed ID: 30829128 [No Abstract] [Full Text] [Related]
24. The diversion of nonscheduled psychoactive prescription medications in the United States, 2002 to 2017. Kurtz SP; Buttram ME; Margolin ZR; Wogenstahl K Pharmacoepidemiol Drug Saf; 2019 May; 28(5):700-706. PubMed ID: 30909323 [TBL] [Abstract][Full Text] [Related]
25. Diversion of drugs within health care facilities, a multiple-victim crime: patterns of diversion, scope, consequences, detection, and prevention. Berge KH; Dillon KR; Sikkink KM; Taylor TK; Lanier WL Mayo Clin Proc; 2012 Jul; 87(7):674-82. PubMed ID: 22766087 [TBL] [Abstract][Full Text] [Related]
26. Implications for a System of Care in Hawai'i for Criminal Justice and Substance Use. Redulla JK; Nikogosyan G Hawaii J Health Soc Welf; 2022 Dec; 81(12 Suppl 3):12-18. PubMed ID: 36660276 [TBL] [Abstract][Full Text] [Related]
27. Help seeking by health professionals for addiction: A mixed studies review. Kunyk D; Inness M; Reisdorfer E; Morris H; Chambers T Int J Nurs Stud; 2016 Aug; 60():200-15. PubMed ID: 27297381 [TBL] [Abstract][Full Text] [Related]
28. The diversion of prescription drugs by health care workers in Cincinnati, Ohio. Inciardi JA; Surratt HL; Kurtz SP; Burke JJ Subst Use Misuse; 2006; 41(2):255-64. PubMed ID: 16393746 [TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of electronic- and clinician-delivered screening, brief intervention and referral to treatment for women in reproductive health centers. Olmstead TA; Yonkers KA; Ondersma SJ; Forray A; Gilstad-Hayden K; Martino S Addiction; 2019 Sep; 114(9):1659-1669. PubMed ID: 31111591 [TBL] [Abstract][Full Text] [Related]
30. Misuse of Methylphenidate. Clemow DB Curr Top Behav Neurosci; 2017; 34():99-124. PubMed ID: 26695166 [TBL] [Abstract][Full Text] [Related]
31. Gender-specific participation and outcomes among jail diversion clients with co-occurring substance use and mental health disorders. Robertson AG; Easter MM; Lin HJ; Khoury D; Pierce J; Swanson J; Swartz M J Subst Abuse Treat; 2020 Aug; 115():108035. PubMed ID: 32600621 [TBL] [Abstract][Full Text] [Related]
32. Error and bias in the evaluation of prescription opioid misuse: should the FDA regulate clinical assessment tools? Meltzer EC; Hall WD; Fins JJ Pain Med; 2013 Jul; 14(7):982-7. PubMed ID: 23594383 [TBL] [Abstract][Full Text] [Related]
33. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS). Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687 [TBL] [Abstract][Full Text] [Related]
34. Risk factors for prescription drug diversion among people living with HIV: a systematic scoping review. Chibi B; Torres NF; Sokhela ZP; Mashamba-Thompson TP Int J Evid Based Healthc; 2020 Mar; 18(1):5-23. PubMed ID: 31162270 [TBL] [Abstract][Full Text] [Related]
35. The diversion of stimulant medications among a convenience sample of college students with current prescriptions. Gallucci AR; Martin RJ; Usdan SL Psychol Addict Behav; 2015 Mar; 29(1):154-61. PubMed ID: 25134041 [TBL] [Abstract][Full Text] [Related]
36. The use of prescription monitoring programs to reduce opioid diversion and improve patient safety. Morgan L; Weaver M; Sayeed Z; Orr R J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):4-9. PubMed ID: 23190160 [TBL] [Abstract][Full Text] [Related]
37. The extent that health professionals suspect and address addiction to medicines in primary care: Findings from a survey in Northwest England. Bates G; Cochrane M; Mackridge AJ J Addict Dis; 2017; 36(3):147-150. PubMed ID: 28323547 [TBL] [Abstract][Full Text] [Related]
38. Recognizing Potential Buprenorphine Medication Misuse: Product Packaging Does Not Degrade With Laundering. Gunderson EW Subst Abus; 2015; 36(2):161-5. PubMed ID: 25811238 [TBL] [Abstract][Full Text] [Related]
39. How to Conduct a Safe Intervention for Substance Use Disorder and What to Avoid. Garcia R Nurs Clin North Am; 2023 Jun; 58(2):197-205. PubMed ID: 37105654 [TBL] [Abstract][Full Text] [Related]
40. Substance use and mental illness among nurses: workplace warning signs and barriers to seeking assistance. Cares A; Pace E; Denious J; Crane LA Subst Abus; 2015; 36(1):59-66. PubMed ID: 25010597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]